• 23 Sep 25
 

MyCelx Tech. Corp. - Result of Annual Meeting

MyCelx Technologies Corp. | MYX | 24.5 0 0.0% | Mkt Cap: 5.97m


 
RNS Number : 5085A
MyCelx Technologies Corporation
23 September 2025
 

23 September 2025

 

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX or MYXR)

 

Result of Annual Meeting

 

 

The Company is pleased to announce that, at its Annual Meeting held on 23 September 2025 at the offices of Cavendish Capital Markets Limited, One Bartholomew Close, London EC1A 7BL, the resolutions set out in the Notice of Annual Meeting were duly passed on a Poll.

 

Full details of the resolutions passed are set out in the Notice of Meeting which is available on the Company's website www.mycelx.com.

 

Resolutions

For / Discretion

Against

Total

Vote withheld*

Number

%

Number

%

1A To elect Tom Lamb as a Director

 

12,965,359

100.00

 

-

 

-

12,965,359

-

1B To elect Connie Mixon as a Director

12,965,359

100.00

 

-

 

 

 

-

12,965,359

-

1C To elect Haluk (Hal) Alper as a Director

 

12,965,359

100.00

-

-

12,965,359

-

1D To elect Andre Schnabl as a Director

 

12,965,359

100.00

-

-

 

12,965,359

 

-

 

2. Ratification of appointment of BDO USA P.C.as independent registered public accounting firm

 

12,965,359

100.00

-

-

12,965,359

-

 

*'Vote withheld' is not a vote in law and is not counted in the calculation of the proportion of the votes 'For' and 'Against' a resolution.

 

For further information please contact:

 

 

MYCELX TECHNOLOGIES CORPORATION

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

CAVENDISH CAPITAL MARKETS LIMITED (NOMINATED ADVISER AND SOLE BROKER)

Giles Balleny / Callum Davidson (Corporate Finance)

Harriet Ward (Corporate Broking)

Jasper Berry / Michael Johnson (Sales)

 

 

Tel: +44 20 7220 0500

CELICOURT COMMUNICATIONS (FINANCIAL PR)

Mark Antelme

Jimmy Lea

Charlie Denley-Myerson

 

Tel: +44 20 7770 6424



 




 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPKNBPPBKDFCB

Research Tree RNS Article

To continue viewing this RNS article, please advise if you are one of the following:

Return to News Summary